Description
Hypophos 667 mg Tablet is utilized to control elevated phosphate levels in individuals with ESRD. By binding dietary phosphate in the gastrointestinal tract, it prevents phosphate absorption into the bloodstream, aiding in the maintenance of appropriate serum phosphorus levels. The recommended starting dose for adults is 2 tablets per meal, with potential adjustments to achieve desired phosphate control, ensuring that serum calcium levels remain within a safe range. Regular monitoring of calcium and phosphate levels is essential during treatment. Contraindications include hypercalcemia (elevated calcium levels). Potential side effects may encompass nausea, constipation, and hypercalcemia, especially if dosages exceed recommendations. It's crucial to consult a healthcare provider before initiating therapy with Hypophos.
.jpg)
Change Language